ANNUAL REPORT 2022/23 (EARNINGS RELEASE) - Seite 4

Overall, Ambu’s total organic growth is expected to be 7-10% for the 2023/24 financial year, compared to 7.6% in 2022/23.

EBIT margin before special items
For 2023/24 the EBIT margin before special items is expected to be 8-10%, compared to 6.3% in 2022/23. This will be driven by an improved gross margin from a strengthened product mix, as well as from a continued overarching cost focus. Ambu’s free cash flow before acquisitions is expected to improve to around DKK +270m, compared to DKK 192m in 2022/23. The continued increased cash flow will be driven by a higher EBIT margin before special items and continued annual savings from the cost reduction program, reflecting a disciplined capital allocation.

ANNUAL GENERAL MEETING
Ambu’s Annual General Meeting 2023 will be held on Wednesday 13 December 2023 at 13.00 (CET) at the headquarters of Ambu A/S, Baltorpbakken 13, DK-2750 Ballerup.

CONFERENCE CALL
An investor conference call will be held today, Wednesday 8 November 2023, at 11:00 (CET).
The conference will be broadcast live via Ambu.com/webcastQ42023.

To ask questions during the Q&A session, please register prior to the call via Ambu.com//conferencecallQ42023register.

Upon registration, you will receive dedicated dial-in details via e-mail to access the call, including a passcode, a unique PIN, dial-in numbers and a calendar invitation.

The presentation will be made available for download at Ambu.com/presentations.

Ambu A/S
Baltorpbakken 13
2750 Ballerup
Denmark
Tel. [phone]
CVR no.: 63 64 49 19
www.Ambu.com

CONTACT

Investors
Anders Hjort
Head of Investor Relations
[e-mail]
[phone]

Media
Tine Bjørn Schmidt
Head of Corporate Communications
[e-mail]
[phone]

ABOUT AMBU

Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,400 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.